Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.
25 Jun, 2021 | 10:37h | UTC
Commentary on Twitter
#COVID19 Associated Pulmonary Aspergillosis
?increasing, associated with excess mortality
?complex: colonization + tissue/angio-invasion
?diagnose? bronchoscopy/BAL
?antifungals recommended
?consider discontinuating/tapering steroids in no respondershttps://t.co/HhS6wUfibn pic.twitter.com/CJwE3CEXxn— Intens Care Med (@yourICM) June 23, 2021